Пей таблетки! | MedIQLab

📈 Analytical overview of Telegram channel Пей таблетки! | MedIQLab

Channel Пей таблетки! | MedIQLab (@mediq) in the Russian language segment is an active participant. Currently, the community unites 66 584 subscribers, ranking 211 in the Medicine category and 8 968 in the Russia region.

📊 Audience metrics and dynamics

Since its creation on невідомо, the project has demonstrated rapid growth, gathering an audience of 66 584 subscribers.

According to the latest data from 18 July, 2026, the channel demonstrates stable activity. Although there has been a change in the number of participants by -459 over the last 30 days and by -11 over the last 24 hours, overall reach remains high.

• Verification status: Not verified
• Engagement rate (ER): The average audience engagement rate is 18.96%. Within the first 24 hours after publication, content typically collects 7.96% reactions from the total number of subscribers.
• Post reach: On average, each post receives 12 625 views. Within the first day, a publication typically gains 5 302 views.
• Reactions and interaction: The audience actively supports content: the average number of reactions per post is 210.
• Thematic interests: Content is focused on key topics such as вакцина, симптом, печень, добавка, прививка.

📝 Description and content policy

The author describes the resource as a platform for expressing subjective opinions:
“Рассказываем о лекарствах, болезнях и доказательной медицине 🔥 Наши авторы — врачи, провизоры и ученые 📱 Мы в MAX: max.ru/mediqlab 💊 Проверить эффективность лекарств — mediqlab.com 💬 Сотрудничество @mediqlab_admin Медиа компании «Б3-МЕД»”

Thanks to the high frequency of updates (latest data received on 19 July, 2026), the channel maintains relevance and a high level of publication reach. Analytics show that the audience actively interacts with content, making it an important point of influence in the Medicine category.